Fibroadenoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{HL}} | {{CMG}} {{AE}} {{HL}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of fibroadenoma are obesity, eostrogen replacement therapy, and nulliparity. | Common risk factors in the development of fibroadenoma are obesity, eostrogen replacement therapy, and nulliparity.<ref name="pmid9754521">{{cite journal| author=Greenberg R, Skornick Y, Kaplan O| title=Management of breast fibroadenomas. | journal=J Gen Intern Med | year= 1998 | volume= 13 | issue= 9 | pages= 640-5 | pmid=9754521 | doi= | pmc=PMC1497021 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9754521 }} </ref> | ||
==Risk Factors== | ==Risk Factors== | ||
* The table below lists the risk factors involved in the development of fibroadenoma: | * The table below lists the risk factors involved in the development of fibroadenoma: |
Revision as of 16:08, 1 February 2016
Fibroadenoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fibroadenoma risk factors On the Web |
American Roentgen Ray Society Images of Fibroadenoma risk factors |
Risk calculators and risk factors for Fibroadenoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Common risk factors in the development of fibroadenoma are obesity, eostrogen replacement therapy, and nulliparity.[1]
Risk Factors
- The table below lists the risk factors involved in the development of fibroadenoma:
Risk Factor | Description |
---|---|
Obesity | An increase in BMI is correlated with an increased risk of fibroadenoma development. |
Estrogen replacement therapy | Estrogen replacement therapy is correlated with an increased risk of fibroadenoma development. |
Pregnancy | Nulliparous women are associated with an increased risk of fibroadenoma development. Whereas multiparous women are associated with a lower risk of fibroadenoma development. |
Contraception | The use of oral contraceptive pills is associated with a lower risk of fibroadenoma development as compared to other contraceptive methods. |
Socioeconomic status | A higher socioeconomic status is correlated with an increased risk of fibroadenoma development. |